Long-term outcomes of ketogenic diet in patients with tuberous sclerosis complex-derived epilepsy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Youn, Song Ee | - |
dc.contributor.author | Park, Soyoung | - |
dc.contributor.author | Kim, Se Hee | - |
dc.contributor.author | Lee, Joon Soo | - |
dc.contributor.author | Kim, Heung Dong | - |
dc.contributor.author | Kang, Hoon-Chul | - |
dc.date.accessioned | 2021-08-11T08:34:08Z | - |
dc.date.available | 2021-08-11T08:34:08Z | - |
dc.date.issued | 2020-08 | - |
dc.identifier.issn | 0920-1211 | - |
dc.identifier.issn | 1872-6844 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/2617 | - |
dc.description.abstract | Objective: For epilepsy with tuberous sclerosis complex (TSC), ketogenic diet (KD) therapy has been consistently reported to be more beneficial than the average KD therapy response. Herein, we aimed to investigate the longterm outcomes of a KD on patients with TSC and intractable epilepsy. Methods: This study included 31 patients with intractable epilepsy and TSC who were treated with the KD, and an intention-to-treat analysis was performed. Results: Overall, 21 of the 31 patients (67.7%) had > 50% reduction in seizures at 3 months after initiating the KD. Thirteen of the 31 patients (41.9%) were seizure-free for at least 3 months, but 10 of these 13 patients (76.9%) experienced seizure recurrence during the 24-month follow-up period. Finally, at 24 months of the KD observational period, there was > 50% response in 10 of the 31 patients (32.3%), including seizure-free patients (6 of 31 patients, 19.4%). Most of the patients (12 of 13, 92.3%) who experienced seizure freedom had > 50% reduction in seizures within 1 month after initiating the KD, and this result was the only factor associated with seizure freedom in the current study. Conclusion: The KD appeared to be an effective therapeutic modality for intractable pediatric epilepsy in TSC, but it did not exhibit guaranteed efficacy over a long-term period. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier BV | - |
dc.title | Long-term outcomes of ketogenic diet in patients with tuberous sclerosis complex-derived epilepsy | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1016/j.eplepsyres.2020.106348 | - |
dc.identifier.scopusid | 2-s2.0-85084357864 | - |
dc.identifier.wosid | 000539340300002 | - |
dc.identifier.bibliographicCitation | Epilepsy Research, v.164 | - |
dc.citation.title | Epilepsy Research | - |
dc.citation.volume | 164 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.subject.keywordPlus | MODIFIED ATKINS DIET | - |
dc.subject.keywordPlus | CHILDHOOD EPILEPSY | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | RECURRENCE | - |
dc.subject.keywordPlus | SEIZURES | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | Epilepsy | - |
dc.subject.keywordAuthor | Ketogenic diet | - |
dc.subject.keywordAuthor | Tuberous sclerosis complex | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.